Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,310,718
in 4 filings, $1.2M under 10b5-1 plans

Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-16 Haigh Adrian CHIEF OPERATING OFFICER Sale 10b5-1 −22,222 $10.28 $228K 0
2024-04-16 Haigh Adrian CHIEF OPERATING OFFICER Option exercise · Common Shares 10b5-1 −22,222 $2.31 $51K 449,135
2024-04-15 Haigh Adrian CHIEF OPERATING OFFICER Option exercise 10b5-1 +22,222 $2.31 $51K 22,222
2024-04-15 Haigh Adrian CHIEF OPERATING OFFICER Sale 10b5-1 +22,222 $2.31 $51K 22,222
2024-04-15 Haigh Adrian CHIEF OPERATING OFFICER Sale 10b5-1 −22,222 $10.30 $229K 22,222
2024-04-15 Haigh Adrian CHIEF OPERATING OFFICER Option exercise · Common Shares 10b5-1 −22,222 $2.31 $51K 471,357
2024-04-15 RALLIS CHRIS A Director Sale 10b5-1 −800 $10.45 $8K 44,449
2024-04-15 RALLIS CHRIS A Director Option exercise 10b5-1 +1,389 $10.45 $15K 45,838
2024-04-15 RALLIS CHRIS A Director Option exercise · Common Shares 10b5-1 −1,389 $3.60 $5K 181,594
2024-04-05 Raykov Rosty CHIEF EXECUTIVE OFFICER Sale 10b5-1 −44,300 $10.75 $476K 187,471
2024-04-04 Raykov Rosty CHIEF EXECUTIVE OFFICER Sale 10b5-1 −14,583 $10.89 $159K 261,471
2024-04-04 Raykov Rosty CHIEF EXECUTIVE OFFICER Sale 10b5-1 −29,700 $10.89 $324K 231,771
2024-04-03 Raykov Rosty CHIEF EXECUTIVE OFFICER Sale 10b5-1 −14,584 $10.78 $157K 302,054
2024-04-03 Raykov Rosty CHIEF EXECUTIVE OFFICER Sale 10b5-1 −26,000 $10.78 $280K 276,054
2024-04-01 Andrade Robert CHIEF FINANCIAL OFFICER Purchase +12,500 104,271
2024-04-01 Raykov Rosty CHIEF EXECUTIVE OFFICER Purchase +29,167 316,638
2024-03-26 RALLIS CHRIS A Director Sale 10b5-1 −2,114 $10.97 $23K 40,920
2024-03-26 RALLIS CHRIS A Director Option exercise 10b5-1 +4,329 $2.31 $10K 45,249
2024-03-26 RALLIS CHRIS A Director Option exercise · Common Shares 10b5-1 −4,329 $2.31 $10K 182,983
2024-03-26 Andrade Robert CHIEF FINANCIAL OFFICER Sale −13,975 $10.90 $152K 91,771

Page 15 of 17 · 340 trades